EMA Authorised: Macitentan Accord (macitentan) — Accord Healthcare

View source ↗

Summary

The EMA authorised Macitentan Accord for treatment of pulmonary arterial hypertension; the marketing authorisation holder is Accord Healthcare.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Macitentan Accord (macitentan)

Snippet

Status: Authorised. Therapeutic area: Hypertension, Pulmonary. MAH: Accord Healthcare. Decision date: 24/09/2025